Approval · Notice of Compliance 7845 · 2006
FASTURTEC: Notice of Compliance 7845
Issued March 29, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7845
- Date
- March 29, 2006
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Uricolytic agent
Products in this notice
Medicinal ingredients
- RASBURICASE 1.5 MG per VIAL
- RASBURICASE 7.5 MG per VIAL